Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Science minister David Willetts

Universities to ‘pick up pharma’s R&D mantle’ after Pfizer closure

March 3, 2011 Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, UK research, UK science, job cuts

Science in the UK will have to focus on contractually-based research in the future as pharma’s R&D presence in the …
News
GlaxoSmithKline's London headquarters

GSK to reimburse tuition fees for UK trainees

March 3, 2011 Business Services, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, UK science, careers, graduate, graduate recruitment

GlaxoSmithKline is set to reimburse UK university tuition fees paid by its trainees from 2012. Each year, GSK recruits between …
News
The RNA interference process

RNA interference – still the great white hope?

March 3, 2011 Manufacturing and Production, Research and Development RNA interference, rnai

The emerging field of RNA interference – also known as ‘gene silencing’ – is one of the most promising in …
Feature

UCB teams up with Harvard for CNS research

March 2, 2011 Research and Development CNS, Harvard, UCB, academia, academic research, immunology

UCB has signed a new research collaboration with Harvard University that will focus on central nervous system and immunology therapies. …
News
brecon_kay_ohagan

Boehringer’s Kay O’Hagan moves to Brecon

March 2, 2011 Manufacturing and Production, Research and Development Brecon, Kay O'Hagan, appointment, manufacturing and production, research and development

Kay O’Hagan has joined commercial packaging and clinical trials supply services company Brecon Pharmaceuticals as director of quality assurance and …
Appointment

GlaxoSmithKline seeks alliances with ‘academic superstars’

March 2, 2011 Research and Development GSK, GlaxoSmithKline, Pentraxin Therapeutics, academia, al Free and University College Medical School, universities

GlaxoSmithKline has unveiled a partnership with a ‘superstar academic’, as part of a new strategy which it believes will help …
News

Daiichi Sankyo gains rights to potential blockbuster cancer drug

March 2, 2011 Research and Development BRAF protein, Daiichi Sankyo, PLX4032, Plexxikon, melanoma, personalised medicine

Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …
News
Bayer's Marijn Dekkers

Bayer goes for pharma growth

March 1, 2011 Research and Development, Sales and Marketing 2010 pharma results, Bayer, Dr Jörg Reinhardt, Marijn Dekkers, Nexavar, VEGF Trap-Eye, Xarelto

While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …
Feature

Pfizer drops 15 pipeline projects

March 1, 2011 Research and Development Lyrica, Pfizer, Pfizer R&D, Pfizer product pipeline, Pfizer research, inotuzumab, pregabalin

Pfizer has again slimmed down its product pipeline as the US giant looks to cut R&D spending and sharpen its …
News

Friedhelm Felten to head procurement at Merck

March 1, 2011 Manufacturing and Production, Research and Development Friedhelm Felten, Merck KGaA, appointment, manufacturing and production, research and development

Merck KGaA has appointed Friedhelm Felten as its new head of corporate procurement with responsibility for the group’s global purchasing …
Appointment

Forest depression candidate struggles against placebo

March 1, 2011 Research and Development Forest, Forest Laboratories, Gedeon Richter, cariprazine, depression, major depressive disorder

An investigational antipsychotic drug being developed by Forest Laboratories and Budapest-based Gedeon Richter has failed to prove itself in phase …
News

Pfizer in break up talks for Sandwich research site

March 1, 2011 Research and Development Kent, Pfizer, Sandwich, job cuts

Pfizer is in confidential talks over the future of its Sandwich, Kent research facility that could see the site broken …
News

Service Insight: Discovery metrics – creating the right balance

February 28, 2011 Research and Development Atkinson Cowan, Kinapse, Service Insight, metrics, research and development

SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in the pharmaceutical industry over the …
Feature
viiv_gsk_pfizer_david_redfern

David Redfern appointed ViiV chairman

February 28, 2011 Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing

David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.
Appointment

Vertex’s cystic fibrosis drug shows huge promise

February 28, 2011 Research and Development, Sales and Marketing VX-770, Vertex, cystic fibrosis

US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026